Inventor · disambiguated record
Pierre Launay
Also filed as: LAUNAY PIERRE · LAUNAY PIERRE E M
6 granted patents·5 pending applications·83 citations·filing 1990–2021
81Inventor score
Files withINATHERYS3INST NAT SANTE RECH MED3ENDODIAG1INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE)1SAUSSARD PHILIPPE1
Top patents by PatentIndex Score
11 records- 0189US11230605B2Anti-TfR antibodies and their use in treating proliferative and inflammatory disordersINATHERYS·Filed 2016·Granted Jan 25, 2022·54 cites·17 claims
- 0283US9198949B2Method and pharmaceutical composition for use in the treatment of cancerINST NAT SANTE RECH MED·Filed 2013·Granted Dec 1, 2015·5 cites·1 claims
- 0374US10759843B2Method and pharmaceutical composition for use in the treatment of cancerSUSIN SANTOS·Filed 2018·Granted Sep 1, 2020·1 cites·9 claims
- 0460US12037408B2Method of treating a tumor using anti-TfR antibodiesINATHERYS·Filed 2021·Granted Jul 16, 2024·0 cites·3 claims
- 0560US2017362302A1Method and Pharmaceutical Composition for Use in the Treatment of CancerINSERM ( INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2017·Application pending·0 cites
- 0656US2016039908A1Method and Pharmaceutical Composition for use in the Treatment of CancerINST NAT SANTE RECH MED·Filed 2015·Application pending·0 cites
- 0751US2005074850A1Novel calcium channels and uses thereofSYNTA PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 0845US5118246AElevating tailgate for vehicle and process of handling itSAUSSARD PHILIPPE·Filed 1990·Granted Jun 2, 1992·23 cites·6 claims
- 0939US2021138083A1Antibody-drug conjucates and their uses for the treatment of cancerINATHERYS·Filed 2019·Application pending·0 cites
- 1036US7892538B2Monovalent ligand of the FcαRI receptor as an anti-inflammatory agentINST NAT SANTE RECH MED·Filed 2005·Granted Feb 22, 2011·0 cites·14 claims
- 1136US2019352415A1Use of the cd71 receptor in the prognosis and treatment of endometriosisENDODIAG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pierre Launay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →